Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gen
Background Single nucleotide polymorphisms (SNPs) in the deoxycytidine kinase (dCK) gene are associa...
Abstract Background Label-retaining cancer cells (LRCC) have been proposed as a model of slowly cycl...
Resistance to chemotherapeutic drugs is one of the major challenges in the treatment of cancer. A be...
BACKGROUND: Gemcitabine is an analogue of deoxycytidine with activity against several solid tumors. ...
BACKGROUND: Gemcitabine is an analogue of deoxycytidine with activity against several solid tumors. ...
Background: The T-cell lymphoma cell line HuT78B1, selected for resistance to Fas-mediated apoptosis...
Background: The T-cell lymphoma cell line HuT78B1, selected for resistance to Fas-mediated apoptosis...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is an inhibitor of ribonucleotide reductase (RR) and DNA polymerization with promising a...
Identifying enzymes that, once introduced in cancer cells, lead to an increased efficiency of treatm...
Background Single nucleotide polymorphisms (SNPs) in the deoxycytidine kinase (dCK) gene are associa...
Abstract Background Label-retaining cancer cells (LRCC) have been proposed as a model of slowly cycl...
Resistance to chemotherapeutic drugs is one of the major challenges in the treatment of cancer. A be...
BACKGROUND: Gemcitabine is an analogue of deoxycytidine with activity against several solid tumors. ...
BACKGROUND: Gemcitabine is an analogue of deoxycytidine with activity against several solid tumors. ...
Background: The T-cell lymphoma cell line HuT78B1, selected for resistance to Fas-mediated apoptosis...
Background: The T-cell lymphoma cell line HuT78B1, selected for resistance to Fas-mediated apoptosis...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is a commonly used therapy for many solid tumors. Acquired resistance to this nucleoside...
Gemcitabine is an inhibitor of ribonucleotide reductase (RR) and DNA polymerization with promising a...
Identifying enzymes that, once introduced in cancer cells, lead to an increased efficiency of treatm...
Background Single nucleotide polymorphisms (SNPs) in the deoxycytidine kinase (dCK) gene are associa...
Abstract Background Label-retaining cancer cells (LRCC) have been proposed as a model of slowly cycl...
Resistance to chemotherapeutic drugs is one of the major challenges in the treatment of cancer. A be...